Hakutulokset - Jonathan D. Cuda

  • Näytetään 1 - 5 yhteensä 5 tuloksesta
Tarkenna hakua
  1. 1
    Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system

    Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system Tekijä Lysandra Voltaggio, Ashley Cimino‐Mathews, Justin A. Bishop, Pedram Argani, Jonathan D. Cuda, Jonathan I. Epstein, Ralph H. Hruban, George J. Netto, Mark H. Stoler, Janis M. Taube, Russell Vang, William H. Westra, Elizabeth A. Montgomery

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade

    Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade Tekijä Genevieve J. Kaunitz, Manisha J. Loss, Hira Rizvi, Sowmya Ravi, Jonathan D. Cuda, Karen B. Bleich, Jessica Esandrio, Inbal Sander, Dung T. Le, Luis A. Díaz, Julie R. Brahmer, Charles G. Drake, Travis J. Hollmann, Mario E. Lacouture, Matthew D. Hellmann, Evan J. Lipson, Janis M. Taube

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Melanoma subtypes demonstrate distinct PD-L1 expression profiles

    Melanoma subtypes demonstrate distinct PD-L1 expression profiles Tekijä Genevieve J. Kaunitz, Tricia R. Cottrell, Mohammed Lilo, Valliammai Muthappan, Jessica Esandrio, Sneha Berry, Haiying Xu, Aleksandra Ogurtsova, Robert A. Anders, Alexander H. Fischer, Stefan Kraft, Meg R. Gerstenblith, Cheryl L. Thompson, Kord Honda, Jonathan D. Cuda, Charles G. Eberhart, James T. Handa, Evan J. Lipson, Janis M. Taube

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab

    Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab Tekijä Nicolás A. Giraldo, Peter Nguyen, Elizabeth L. Engle, Genevieve J. Kaunitz, Tricia R. Cottrell, Sneha Berry, Benjamin Green, Abha Soni, Jonathan D. Cuda, Julie E. Stein, Joel Sunshine, Farah Succaria, Haiying Xu, Aleksandra Ogurtsova, Ludmila Danilova, Candice D. Church, Natalie J. Miller, Steve Fling, Lisa Lundgren, Nirasha Ramchurren, Jennifer H. Yearley, Evan J. Lipson, Mac Cheever, Robert A. Anders, Paul Nghiem, Suzanne L. Topalian, Janis M. Taube

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)

    Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC) Tekijä Tricia R. Cottrell, Elizabeth D. Thompson, Patrick M. Forde, Julie E. Stein, Amy S. Duffield, Valsamo Anagnostou, Natasha Rekhtman, Robert A. Anders, Jonathan D. Cuda, Peter B. Illei, E Gabrielson, Frederic B. Askin, Noushin Niknafs, Kellie N. Smith, Moises J. Velez, Jennifer L. Sauter, James M. Isbell, David R. Jones, Richard J. Battafarano, Stephen C. Yang, L. Danilova, Jedd D. Wolchok, Suzanne L. Topalian, Victor E. Velculescu, Drew M. Pardoll, Julie R. Brahmer, Matthew D. Hellmann, Jamie E. Chaft, Ashley Cimino‐Mathews, Janis M. Taube

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: